These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 34301992)

  • 41. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
    Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
    Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive PKD1 and PKD2 Mutation Analysis in Prenatal Autosomal Dominant Polycystic Kidney Disease.
    Audrézet MP; Corbiere C; Lebbah S; Morinière V; Broux F; Louillet F; Fischbach M; Zaloszyc A; Cloarec S; Merieau E; Baudouin V; Deschênes G; Roussey G; Maestri S; Visconti C; Boyer O; Abel C; Lahoche A; Randrianaivo H; Bessenay L; Mekahli D; Ouertani I; Decramer S; Ryckenwaert A; Cornec-Le Gall E; Salomon R; Ferec C; Heidet L
    J Am Soc Nephrol; 2016 Mar; 27(3):722-9. PubMed ID: 26139440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of novel mutations of PKD1 gene in Chinese patients with autosomal dominant polycystic kidney disease by targeted next-generation sequencing.
    Yang T; Meng Y; Wei X; Shen J; Zhang M; Qi C; Wang C; Liu J; Ma M; Huang S
    Clin Chim Acta; 2014 Jun; 433():12-9. PubMed ID: 24582653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients.
    Audrézet MP; Cornec-Le Gall E; Chen JM; Redon S; Quéré I; Creff J; Bénech C; Maestri S; Le Meur Y; Férec C
    Hum Mutat; 2012 Aug; 33(8):1239-50. PubMed ID: 22508176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autosomal dominant polycystic kidney disease: clues to pathogenesis.
    Harris PC
    Hum Mol Genet; 1999; 8(10):1861-6. PubMed ID: 10469838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. XBP1 Activation Reduces Severity of Polycystic Kidney Disease due to a Nontruncating Polycystin-1 Mutation in Mice.
    Krappitz M; Bhardwaj R; Dong K; Staudner T; Yilmaz DE; Pioppini C; Westergerling P; Ruemmele D; Hollmann T; Nguyen TA; Cai Y; Gallagher AR; Somlo S; Fedeles S
    J Am Soc Nephrol; 2023 Jan; 34(1):110-121. PubMed ID: 36270750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutational Screening of PKD1 and PKD2 Genes in Iranian Population Diagnosed with Autosomal Dominant Polycystic Kidney Disease.
    Ranjzad F; Tara A; Basiri A; Aghdami N; Moghadasali R
    Clin Lab; 2017 Jul; 63(7):1261-1267. PubMed ID: 28792715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development.
    Woo YM; Bae JB; Oh YH; Lee YG; Lee MJ; Park EY; Choi JK; Lee S; Shin Y; Lyu J; Jung HY; Lee YS; Hwang YH; Kim YJ; Park JH
    Hum Genet; 2014 Mar; 133(3):281-97. PubMed ID: 24129831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.
    Freedman BS; Lam AQ; Sundsbak JL; Iatrino R; Su X; Koon SJ; Wu M; Daheron L; Harris PC; Zhou J; Bonventre JV
    J Am Soc Nephrol; 2013 Oct; 24(10):1571-86. PubMed ID: 24009235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. c-Jun N-terminal kinase (JNK) signaling contributes to cystic burden in polycystic kidney disease.
    Smith AO; Jonassen JA; Preval KM; Davis RJ; Pazour GJ
    PLoS Genet; 2021 Dec; 17(12):e1009711. PubMed ID: 34962918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Presumed Synonymous Mutation of PKD2 Caused Autosomal Dominant Polycystic Kidney Disease in a Chinese Family.
    Deng LX; Yang Y; Yang J; Zhou LW; Wang K; Zhou JH
    Curr Med Sci; 2021 Oct; 41(5):1029-1036. PubMed ID: 34542828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.
    Li LX; Fan LX; Zhou JX; Grantham JJ; Calvet JP; Sage J; Li X
    J Clin Invest; 2017 Jun; 127(7):2751-2764. PubMed ID: 28604386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heterotrimeric G protein signaling in polycystic kidney disease.
    Hama T; Park F
    Physiol Genomics; 2016 Jul; 48(7):429-45. PubMed ID: 27199453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.
    Streets AJ; Magayr TA; Huang L; Vergoz L; Rossetti S; Simms RJ; Harris PC; Peters DJ; Ong AC
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F577-F588. PubMed ID: 28077374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease.
    Tan YC; Blumenfeld JD; Anghel R; Donahue S; Belenkaya R; Balina M; Parker T; Levine D; Leonard DG; Rennert H
    Hum Mutat; 2009 Feb; 30(2):264-73. PubMed ID: 18837007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutation Analysis of Autosomal-Dominant Polycystic Kidney Disease Patients.
    Suzuki Y; Katayama K; Saiki R; Hirabayashi Y; Murata T; Ishikawa E; Ito M; Dohi K
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease.
    Wang Q; Cobo-Stark P; Patel V; Somlo S; Han PL; Igarashi P
    Kidney Int; 2018 Feb; 93(2):403-415. PubMed ID: 29042084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Boucher C; Sandford R
    Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiomics profiling of mouse polycystic kidney disease progression at a single-cell resolution.
    Muto Y; Yoshimura Y; Wu H; Chang-Panesso M; Ledru N; Woodward OM; Outeda P; Cheng T; Mahjoub MR; Watnick TJ; Humphreys BD
    Proc Natl Acad Sci U S A; 2024 Oct; 121(43):e2410830121. PubMed ID: 39405347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
    Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
    J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.